Financhill
Back

Louisiana-Pacific Vs. Viking Therapeutics Industry Stock Comparison

Sell
40

LPX
Louisiana-Pacific

Last Price:
$89.49
Seasonality Move:
4.89%
Sell
31

VKTX
Viking Therapeutics

Last Price:
$27.96
Seasonality Move:
2.26%
Sell
40
Louisiana-Pacific (LPX) is a Sell

Is Louisiana-Pacific a Buy, Sell or Hold?

  • The current Louisiana-Pacific [LPX] share price is $92.83. The Score for LPX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LPX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $29.10. The Score for VKTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LPX Stock Price Chart

What is Louisiana-Pacific's stock price today?

  • The Louisiana-Pacific share price today is $92.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LPX is experiencing slight buying pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $29.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

LPX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.91 Sell
Relative Strength Index (14 RSI): 25.62 Sell
Chaikin Money Flow: 178510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.04 - 115.92) Sell
Bollinger Bands (100): (101.84 - 116.1) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 44.89 Sell
Chaikin Money Flow: 1618890 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.18 - 32.44) Sell
Bollinger Bands (100): (31.92 - 60.4) Sell

LPX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.89 Sell
20-day SMA: 104.35 Sell
50-day SMA: 108.25 Sell
200-day SMA: 101.28 Sell
8-day EMA: 96.8 Sell
20-day EMA: 102.21 Sell
50-day EMA: 106.76 Sell
200-day EMA: 100.41 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.11 Buy
20-day SMA: 29.7 Sell
50-day SMA: 34.14 Sell
200-day SMA: 52.38 Sell
8-day EMA: 28.65 Buy
20-day EMA: 29.94 Sell
50-day EMA: 34.89 Sell
200-day EMA: 46.22 Sell

Louisiana-Pacific Earnings Growth & LPX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.18 per share, and an increase next year of $0.59 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.57 per share.

Louisiana-Pacific Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):